Cargando…
Correction to: Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma
Autores principales: | Lu, Chenying, Fang, Shiji, Weng, Qiaoyou, Lv, Xiuling, Meng, Miaomiao, Zhu, Jinyu, Zheng, Liyun, Hu, Yumin, Gao, Yang, Wu, Xulu, Mao, Jianting, Tang, Bufu, Zhao, Zhongwei, Huang, Li, Ji, Jiansong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580011/ https://www.ncbi.nlm.nih.gov/pubmed/33092596 http://dx.doi.org/10.1186/s12964-020-00674-y |
Ejemplares similares
-
Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma
por: Lu, Chenying, et al.
Publicado: (2020) -
Identifying Apoptosis-Related Transcriptomic Aberrations and Revealing Clinical Relevance as Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
por: Zhu, Jinyu, et al.
Publicado: (2021) -
A role for the NPM1/PTPN14/YAP axis in mediating hypoxia-induced chemoresistance to sorafenib in hepatocellular carcinoma
por: Zhang, Dengke, et al.
Publicado: (2022) -
Identification and validation of the angiogenic genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma
por: Zhu, Jinyu, et al.
Publicado: (2020) -
Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
por: Zheng, Liyun, et al.
Publicado: (2021)